4.2 Article

Serum PCSK9 levels in infants with deviant birth weight: a biomarker of the lipoprotein metabolism

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pediatrics

A comparison of the maternal levels of serum proprotein convertase subtilisin/kexin type 9 in pregnant women with the complication of fetal open neural tube defects

Seyit Ahmet Erol et al.

Summary: The study found that maternal serum PCSK9 levels were associated with open NTDs, potentially playing a role in fetal neuronal differentiation. PCSK9 may serve as an additional biomarker for screening NTDs, but further research is needed for validation.

CONGENITAL ANOMALIES (2021)

Review Medicine, General & Internal

Metabolic Disease Programming: From Mitochondria to Epigenetics, Glucocorticoid Signalling and Beyond

Luis F. Grilo et al.

Summary: Embryonic and foetal development are critical periods during which environmental cues can impact long-term health outcomes, predisposing offspring to metabolic diseases. Recent research focuses on identifying molecular mechanisms in developmental programming that contribute to increased susceptibility to metabolic diseases in offspring.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Endocrinology & Metabolism

Novel therapeutic targets and agents for pediatric dyslipidemia

Bhuvana Sunil et al.

Summary: Landmark studies have shown that atherosclerosis begins in youth and more youth with lipid and lipoprotein disorders are being identified through screening. Existing lipid-lowering therapy for youth is safe but response may vary, indicating a need for new agents and approaches. Clinical trials on novel therapeutic agents for cholesterol and triglycerides are ongoing in youth, with a focus on altering lipid and lipoprotein metabolism.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2021)

Article Cardiac & Cardiovascular Systems

Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study

Wuxiang Xie et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Editorial Material Pediatrics

Born Large for Gestational Age: Bigger Is Not Always Better

Valentina Chiavaroli et al.

JOURNAL OF PEDIATRICS (2016)

Article Biochemistry & Molecular Biology

Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction

Ulrich Pecks et al.

LIPIDS IN HEALTH AND DISEASE (2016)

Article Obstetrics & Gynecology

Developmental origins of health and disease - Global public health implications

M. A. Hanson et al.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2015)

Article Obstetrics & Gynecology

Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants

Shunsuke Araki et al.

EARLY HUMAN DEVELOPMENT (2014)

Review Nutrition & Dietetics

Epigenetic programming of obesity and diabetes by in utero exposure to gestational diabetes mellitus

Stephanie-May Ruchat et al.

NUTRITION REVIEWS (2013)

Article Obstetrics & Gynecology

Maternal and fetal cord blood lipids in intrauterine growth restriction

Ulrich Pecks et al.

JOURNAL OF PERINATAL MEDICINE (2012)

Article Medicine, General & Internal

Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol

Evan A. Stein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Endocrinology & Metabolism

Genetic and Metabolic Determinants of Plasma PCSK9 Levels

Susan G. Lakoski et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Article Genetics & Heredity

A spectrum of PCSK9 Alleles contributes to plasma levels of low-density lipoprotein cholesterol

IK Kotowski et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2006)

Article Multidisciplinary Sciences

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):: Liver regeneration and neuronal differentiation

NG Seidah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)